SEER Study: Surgery Still Extends Mesothelioma SurvivalResearch & Clinical Trials
Asbestos.com is the nation’s most trusted mesothelioma resource
The Mesothelioma Center at Asbestos.com has provided patients and their loved ones the most updated and reliable information on mesothelioma and asbestos exposure since 2006.
Our team of Patient Advocates includes a medical doctor, a registered nurse, health services administrators, veterans, VA-accredited Claims Agents, an oncology patient navigator and hospice care expert. Their combined expertise means we help any mesothelioma patient or loved one through every step of their cancer journey.
More than 30 contributors, including mesothelioma doctors, survivors, health care professionals and other experts, have peer-reviewed our website and written unique research-driven articles to ensure you get the highest-quality medical and health information.
About The Mesothelioma Center at Asbestos.com
- Assisting mesothelioma patients and their loved ones since 2006.
- Helps more than 50% of mesothelioma patients diagnosed annually in the U.S.
- A+ rating from the Better Business Bureau.
- 5-star reviewed mesothelioma and support organization.
"My family has only the highest compliment for the assistance and support that we received from The Mesothelioma Center. This is a staff of compassionate and knowledgeable individuals who respect what your family is experiencing and who go the extra mile to make an unfortunate diagnosis less stressful. Information and assistance were provided by The Mesothelioma Center at no cost to our family."LashawnMesothelioma patient’s daughter
How to Cite Asbestos.com’s Article
Povtak, T. (2020, October 16). SEER Study: Surgery Still Extends Mesothelioma Survival. Asbestos.com. Retrieved December 7, 2022, from https://www.asbestos.com/news/2016/01/20/seer-study-surgery-extends-mesothelioma-survival/
Povtak, Tim. "SEER Study: Surgery Still Extends Mesothelioma Survival." Asbestos.com, 16 Oct 2020, https://www.asbestos.com/news/2016/01/20/seer-study-surgery-extends-mesothelioma-survival/.
Povtak, Tim. "SEER Study: Surgery Still Extends Mesothelioma Survival." Asbestos.com. Last modified October 16, 2020. https://www.asbestos.com/news/2016/01/20/seer-study-surgery-extends-mesothelioma-survival/.
Aggressive surgery at a specialty center could more than double the survival period of a patient diagnosed today with malignant pleural mesothelioma.
Surgery may buy precious time.
Although oncologists and patients often advise and opt against it, surgery remains an effective tool that significantly extends lives, according to an analysis of 14,228 mesothelioma patients across the U.S. The sample of patients is among the largest in similar studies.
“There are limitations to the data, but people just do better with surgery,” thoracic surgeon Andrea Wolf, of Mount Sinai Medical Center in New York City, told Asbestos.com. “No matter how you slice it, surgery seems to improve survival.”
The analysis revealed a median survival of 14.5 months for patients who had surgery but 6.5 months for those who did not. There was a five-year survival rate of 15 percent for those who underwent surgery and less than 1 percent for those who did not.
Only 23 percent of the patients in the analysis had surgery. The sampling was taken from 1973-2009 as part of the Surveillance, Epidemiology and End Results (SEER) database. PLOS One, a multidisciplinary Open Access Scientific Journal, published the Mount Sinai Medical staff analysis in December 2015.
SEER Cancer Database Is All-Inclusive
The SEER database includes a wide sampling of unselected cancer patients who share pleural mesothelioma tumor characteristics at diagnosis. All cell types of mesothelioma were used in the analysis.
- Total and partial resections
- Extrapleural pneumonectomies
- Pleurectomy/decortication procedures
The analysis confirmed the advantage of surgery on survival was not because of differences in patient characteristics among those who had surgery, but it was based on a propensity score analysis adjusted for age, sex and stage of disease.
“For people who say there is no role for surgery [with mesothelioma], this argues against that,” Wolf said. “This was not a carefully selected subset of patients. This was everyone. You tend to think now that surgery really makes a difference.”
Although significant progress in treating mesothelioma has been made in the last few years, the SEER data analysis did not reflect it. There was no marked difference in survival times between the 1973-1999 and 2000-2009 periods.
The median age at diagnosis was 62, more than half of the cases were diagnosed with distant metastases, and three-quarters of the patients were male.
Within a multivariable analysis, younger age, early stage, female gender, epithelial histology and treatment with surgery are independent predictors of longer survival.
Hope Still Abounds for People with Mesothelioma
“There is absolutely hope for these people today,” Wolf said. “There are treatment options, and there is reason for hope. I can’t tell you how many people I see who were told elsewhere, ‘Just get your affairs in order. There is nothing we can do.’ The fact is, people can survive with this disease if treated correctly.”
Wolf tells a story about a patient who came to her with advanced-stage disease. He had been told he had six months to live and nothing really could be done for him.
He came under her care and had surgery. Four years later, she watched him proudly walk his daughter down the aisle on her wedding day.
“There are patients out there who seem to have everything working against them, advanced age, advanced disease, biphasic cell type, but they just keep going and the therapy works,” she said. “Every patient is different. You give them the benefit of the doubt. People can do well.”